Drugmaker Elder Pharmaceuticals is exploring options to sell its nutrition products business, two sources with direct knowledge of the development said.
One of the sources said Elder is looking for a valuation of roughly $60 million to $75 million for the business, which includes about 20 brands, and that discussions are at a very early stage.
Elder Pharma Joint Managing Director Alok Saxena denied that the company was looking to sell the business.
"We are not selling anything, nor are we discussing this with anybody," Saxena said in an emailed reply to a query from Reuters.
The nutrition supplements market in India, home to more than 1.3 billion people, is relatively undeveloped and valued at about USD 1 billion, according to the lobby group Federation of Indian Chambers of Commerce and Industry.
A rapidly expanding middle-class, increasing incidence of diabetes and longer life spans are driving demand for nutrition products in India, an opportunity that has caught the attention of multinationals.
Last year, French drugmaker Sanofi's
Elder Pharma stock price
On November 30, 2015, Elder Pharmaceuticals closed at Rs 86.25, up Rs 0.15, or 0.17 percent. The 52-week high of the share was Rs 167.00 and the 52-week low was Rs 66.65.
The latest book value of the company is Rs 382.51 per share. At current value, the price-to-book value of the company was 0.23.
Set email alert for
ADS BY GOOGLE
video of the day
Mkt resilient at current level; bullish auto: ICICI Pru AMC